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1. Introduction 
Prenatal diagnosis of severe disability and the option of termination of pregnancy (TOP) 
have been widely available to parents in most countries in the Western world for three 
decades. This has come to be known as selective abortion. The ethics of this procedure is a 
large subject that I will not attempt to address in this paper. Some countries have laws that 
forbid selective abortion unless the mother’s life is at risk. Where neural tube defects (NTDs) 
are concerned, medical opinion might favour TOP in a mother carrying an anencephalic 
fetus. The anencephalic infant will not normally survive for more an hour after birth but the 
mother may have a difficult and even life threatening labour because the lack of a fetal head 
prevents normal labour from progressing. The pregnancy tends to go overdue and vaginal 
delivery is complicated by shoulder dystocia and can be very difficult and hazardous for the 
mother. However 60% of women in the world would not be able to access an early TOP for 
this type of pregnancy due to poverty, religious reasons or anti-abortion legislation. In the 
republic of Ireland, which has anti-abortion legislation, this situation has encouraged 
legislators to consider minimising the need for selective abortion by introducing mandatory 
fortification of flour with folic acid (FA). 
1.1 Objections to folic acid fortification of bread, flour and grain 
Scientists, oncologists and politicians have urged caution in implementing folic acid 
fortification of bread, flour and grain. Oncologists were amongst the first to point out that 
many cancer chemotherapy drugs work by inhibiting folate metabolism and subsequent 
research showed that giving folic acid can accelerate tumour growth in animal models 
(Hubner et al., 2007). The arguments for and against fortification depend on the 
interpretation of data from countries where fortification has already been implemented. In 
Chile, which has similar anti-abortion legislation to The Republic of Ireland, a ten year 
policy of fortification has reduced the incidence of NTD births by 40% - from 17/10,000 
births to 10.1/10,000 births (Hertrampf et al., 2004). However the UK and Irish governments 
have held back on fortification and the following issues have caused pause for thought: 
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1.1.1 There has been a slight increase in colorectal and prostate cancer in middle life 
in the USA 
Mandatory FA fortification has been in force for ten years in the USA and Canada and the 
incidence of NTD conceptions has dropped 20-40% varying between different regions of 
North America. However, a slight increase in the incidence of colorectal and prostate cancer 
was noticed which coincided with the introduction of fortification (Mason et al., 2007).The 
latest paper from the USA on colorectal cancer since fortification (n=535,000) showed that 
far from an increased risk, subjects with the highest folate intakes were 30% less likely to 
develop cancers (Gibson et al., 2011). 
1.1.2 Supplementation trials and cancers risk 
A trial comparing FA supplementation and low dose aspirin with placebo suggests that 
giving folic acid 1000 microgram daily increases the risk of middle life cancers, especially 
colorectal and prostate (Cole et al 2007). This is thought to occur in folate replete 
populations when an unnaturally high folate status accelerates cell proliferation in early 
cancers. However, supplementation with folic acid and other B vitamins in folate deficient 
populations and populations where there is a high incidence of the gene for slow folate 
metabolism (MTHFR C677T) may decrease the risk of these cancers (Le Marchand et al., 
2002; Figueiredo et al., 2011). 
1.1.3 Masking of vitamin B12 deficiency 
Masking of B12 deficiency by giving folic acid for macrocytic anaemia was a problem in the 
last century but B12 deficiency is much less likely to go undiagnosed in a modern medical 
setting. However, there have been warnings that folic acid fortification might have an 
adverse effect on B12 status and cognitive function in older age groups (Clarke et al., 2004). 
1.1.4 Folic acid in not a natural substance 
Folates are the natural form of the vitamin and are present in fruit and vegetables whereas 
FA is a synthetic man made substance. However, folates are labile molecules that break 
down with storage and heat. Folic acid is a relatively stable synthetic molecule and is 
quickly metabolised into the folate pathways in small quantities but a high dose may not be 
metabolised so well. High intake of FA results in a measurable residue of circulating folic 
acid which could, theoretically, have adverse effects, on the development of the fetal central 
nervous system for instance (Smith et al., 2008). Research in Ireland has shown that 
fortification that delivers a dose of 100 microgram daily is safe, in this respect. There was no 
detectable unmetabolised serum folic acid at this dose (Sweeney et al, 2007). 
1.1.5 30% of NTD conceptions will still occur 
The precise reason for this is unknown but some genetic combinations may make the 
development of some NTDs inevitable. However, other B vitamins are involved in the 
folate-methionine-homocysteine cycle (Figure 1; McNulty et al., 2002). Instability of this 
cycle and build up of high levels of homocysteine are thought to play a key role in delaying 
neural tube closure (Rosenquist et al., 2002). Zinc deficiency might also be a factor in some 
NTDs (Srinivas et al., 2001). 
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1.2 Benefits from public health measures for prevention of NTDs 
In terms of public health benefit, we should also concern ourselves with the efficacy of folic 
acid fortification compared with the policy in the United Kingdom and other European 
countries where women are encouraged to take folic acid 400 g daily starting about six 
weeks before a planned conception and offered ultrasound screening and the option of TOP 
if a NTD fetus is diagnosed. Is prevention of NTD conceptions by folic acid fortification a 
valid alternative? It has the advantage that the 40% of conceptions that are unplanned but 
not unwanted (Botto et al., 2005; Gipson & Stanelli, 2011) will benefit from this policy 
whereas the UK policy will only achieve an intake of folic acid sufficient to reduce the risk 
of NTD conceptions in 60% of subjects at the very most. However, the concordance rate for 
starting folic acid before conception in planned pregnancies is poor and does not seem to 
make a significant impact on the incidence of NTD conceptions (Botto et al., 2005). The best 
concordance data shows only 10-20% of women with both planned pregnancies and starting 
a folic acid supplement before conception (Rezan et al., 2002).  
 
Fig. 1. Simplified version of the folate-methionine-homocysteine cycle illustrating the role of 
vitamins B2 (riboflavin), B6 (pyridoxine) and B12 (cobalamin) in modulating the cycle and 
directly or indirectly lowering homocysteine burden. 
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1.3 Objections to policy of pre-conception advice with option of selective abortion 
Having listed the objections to fortification, we need to consider the reasons why a policy of 
advising pre-conception folic acid and ultrasound screening for NTDs in early pregnancy 
may be considered unsatisfactory. This will always involve a significant number of women 
being offered TOP as an option when screening shows a NTD fetus. 
1.3.1 Pre-conception folic acid concordance has failed 
The level of success for starting folic acid before conception is too low to make a measurable 
impact on the rate of NTD conceptions. Since the neural tube develops before a woman 
knows she is pregnant, starting folic acid as soon as pregnancy is confirmed will never make 
a noticeable impact on the incidence of NTD conceptions. According to a survey based on 
data for England and Wales published by the UK Office for National Statistics (Morris & 
Wald, 2007) 969 NTD conceptions were recorded in 2004 (801 women had TOPs for NTD 
but 168 were recorded as going to term with NTD infants). The authors estimate that there 
are 1,100 NTD conceptions in the whole of the UK (if Scotland and Northern Ireland are 
included). 
1.3.2 Selective abortion is a psychological trauma 
The distress to mothers who opt for selective abortion for a NTD conception is a significant 
issue. A review of the evidence on the impact of selective abortion concludes that women 
experience a bereavement reaction that is similar to that experienced with a stillbirth 
(Statham et al., 2000). 
1.3.3 Screening misses a significant proportion of NTDs 
The data from Morris and Wald indicates that a significant minority of NTDs are missed on 
ultrasound screening (see 1.2.1) which is approximately 17% of all NTD conceptions. 
However, another source of error is the pregnancies that spontaneously abort due to NTDs 
which has been estimated at 600-1200 per year in the UK (UK Department of Health report 
2000). In at least half of these aborted foetuses NTD is caused by chromosomal abnormalities 
so that folate status has no bearing on aetiology or prevention. However, some women with 
NTD conceptions who spontaneously abort in this way might have benefitted from 
increased intake of FA before conception and they certainly get no benefit from the policy of 
selective abortion. 
1.4 Assessing the case for folic acid fortification in the UK and Ireland 
The success of fortification in Chile and North America is encouraging and the recent data 
on cancers in these countries has reassured the public health experts that the apparent 
increased risk of cancers with fortification is either very small or just a statistical aberration. 
It is particularly significant that the USA and Canada have not wavered from the policy of 
FA fortification. Ultimately, the question of whether fortification is a cost-effective exercise 
has to be addressed. This can be estimated by comparing: A/ costs mandatory fortification 
reimbursed to UK millers by government = government reimbursement to millers for 
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adding folic acid 140 g/100mg + cost of government monitoring B/ government savings 
from mandatory fortification = cost of TOP x drop in number of TOPs done for NTD+ 
lifetime medical cost of treatment for NTD patients x drop in number of NTD births This can 
be estimated for the UK from Morris and Wald’s data on selective abortion for NTDs and live 
NTD births who survive infancy and from research carried out in Surrey (Nichols et al 2008a) 
using data on total folate intake from a women attending local midwives’ booking in clinics. 
2. Estimation of benefits of UK adopting policy of mandatory folic acid 
fortification of flour and bread 
The research carried out by the author and colleagues at The University of Surrey, UK was 
used, with data from other sources, to estimate the impact of fortification for the whole nation. 
2.1 Two groups of women were investigated 
a. Eighteen Surrey women were assessed for dietary folate intake as part of a larger 
research project (Nichols et al 2008b) which assessed dietary folate intake using 
weighed food diet diaries. Each subject was given a seven-day diet diary to complete 
and given the use of battery operated microtonic scales with detailed instructions. 
Research has demonstrated the weighed seven-day diet diary to be a reasonably 
accurate tool for measuring nutrient intake in free-living individuals (Day et al., 2001, 
Nelson et al 1998). The diet diary data was entered into “WinDiets Professional”, a 
computerised database for analysis of nutritional intake (Wise, 1999). The output 
included an estimate of daily folate intake for each of the 18 subjects. Although this was 
a small sample, the mean folate intake at 267 μg/day was very similar to the UK 
national averages from the UK National Diet and Nutritional Survey 2002 (229 μg/day 
for women aged 19-24 yr, 234 μg/day for women aged 25-34 yr). Therefore the figure of 
267 μg/day was assumed to be the approximate dietary intake for group B women and 
the basis for calculating total folate intake by adding together this presumed dietary 
folate and folic acid supplementation in the larger sample of Surrey Group B women 
attending the district midwife booking-in clinic. 
b. 200 women were asked to complete questionnaires when they attended midwives’ 
booking in clinics in the catchment area of The Royal Surrey Count Hospital. The 
response rate was 43.5%. The women were asked to complete the questionnaire and 
return it to the researchers in a stamped addressed envelope. The questions asked the 
following: 
-  whether the pregnancy was planned or unplanned 
- whether the pregnancy was natural or an assisted pregnancy 
- whether a supplement was started before or after conception 
- if before conception, number of weeks taken 
- exactly what brand(s) of supplement was used 
- age, and age at completion of education 
With a good response rate, this sample was thought to be adequate to calculate statistical 
significance for the different amounts of folic acid in the different over-the-counter 
supplements and for estimation of total folate intake (TFI). 
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2.2 Estimation of total folate intake 
Owing to the poor availability of dietary folate resulting from loss of folate content in 
cooking and poor absorption of food folate compared with synthetic folic acid (McKillop et 
al., 2002; Standing committee on the Scientific Evaluation of Dietary Reference Intakes, 
Washington DC, 1998), various authorities have recommended a downward adjustment of 
approximately 50% for dietary folate (Eichholzer et al., 2006) when calculating a combined 
value for dietary folate/day + FA/day (FAD). Therefore, corrected total folate (TFI) was 
calculated using the estimated mean dietary intake for all Group B Surrey women (DM) 
using the formula: 
 TFI  [ DM 2]  FADmg /day    
 
Fig. 2. Relation between controlled folic acid intake and the resulting change in median or 
adjusted mean serum or plasma folate concentration. Data were derived from intervention 
studies looking at the effect of longitudinal folic acid supplementation or fortification with 
known daily amounts of folic acid on median or adjusted mean serum or plasma folate 
concentrations. The broken and dotted lines represent the change in plasma or serum folate 
concentration observed by two research groups (Jacques et al., 2000; Lawrence et al, 1999) 
respectively, in 2 studies examining the effect of the current US folic acid fortification 
regimen on folate status. y = 0.0254x + 0.0514 (r = 0.984, P < 0.0001). 
Reproduced with permission by the American Journal of Clinical Nutrition. , Am J Clin 
Nutr. and authors Quinlivan EP and Gregory JF. 
www.intechopen.com
Selective Abortion and Folic Acid Fortification  
as Contrasting Strategies for Prevention of Congenital Neural Tube Defect 
 
105 
The predicted average uplift from FA fortification at the level of 140 g/100gm of flour TFI 
is 220 g/day (Eichholzer et al., 2006; Quinlivan & Gregory, 2003). Figure 2 was used to 
calculate the uplift of folate intake with fortification which was estimated for women in 
group B using the formula: 
 Estimated TFI after fortification  [ DM 2] FAD  220mg /day     
Since at least 70% of mothers will achieve a serum folate level that prevents the NTD 
malformation on an intake of >700 g/day (Homocysteine Lowering Trialist’s 
Collaboration, 2005; Rosenquist & Finnell 2001) (Figure 1), the data for estimated TFI after 
fortification was analysed using this standard. 24% (21/87) of women attending the DMCs 
had unplanned pregnancies and were younger (mean age 29.8 yr, compared with average 33 
yr). Numerous surveys suggest that the national average for pregnancies that are 
unplanned, but not necessarily unwanted, is 40%. However, there were probably a higher 
proportion of women with unplanned pregnancies among the 113 women who had failed to 
return a completed questionnaire so that the true figure for Surrey women having 
unplanned pregnancies may be closer to the 40% national average. Using the above formula, 
the expected uplift of TFI was estimated for all pregnancies and separately for unplanned 
pregnancies (Table 1). 
 Mean TFI before 
fortification 
Mean TFI after 
fortification 
Increased to 
>700 g/day 
before-after 
fortification 
P 
values 
for 
uplift 
All district 
midwife clinic 
497 g/day 
(95% Cl 358-635) 
717 g/day 
(95% Cl 579-855) 
21%-55%* 0.01 
Unplanned 
pregnancies 
160 g/day 
(95% Cl 81-240) 
380 g/day 
(95% Cl 301-460) 
4.8%-4.8% ns 
* 34% improvement in reaching >700 g/day TFI 
Table 1. Estimated total daily folate acid intake - dietary folate + folic acid (TFI) before and 
after fortification with folic acid 140 g/100 g of flour as implemented in The USA. P values 
are given for the difference between number of subjects with an adequate intake of total 
folate (700 g/day or more) before and after fortification (from Nichols et al., 2008a). 
Only one woman with an unplanned pregnancy had been taking FA 400 g/day (in a 
multivitamin tablet), compared with 75% of women with planned pregnancies. 
2.3 Estimation of expected number of NTD malformations averted with folic acid 
fortification for the UK 
The estimated number of UK NTD conceptions/year is 1100 (Morris & Wald, 2007). If 
fortification achieves a national 34% improvement in the number of women attaining the 
optimal level of daily TFI >700 g/day for prevention of NTDs (Homocysteine Lowering 
Trialist’s Collaboration), this would result in 374 of these 1100 women/year reaching this 
standard. In this “high risk” group, achieving optimal TFI should protect 62-94% (Berry et 
al, 1999) = 232-352 NTD malformations/year averted. Thus approximately 292 infants a year 
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will be born normal and healthy after fortification that are currently either being diagnosed 
as NTD and aborted or born with a NTD malformation. An alternative calculation is based 
on expected rise in serum folate with fortification (Wald et al., 2003). The rise in serum folic 
acid in group B subjects was estimated from FA intake before and after fortification by 
reading off expected plasma folate values from Figure 2: 
Estimated plasma folic acid before fortification  12.6mg /L  
Estimated plasma folic acid after fortification  18.4mg /L  
Estimated change in plasma folic acid  5.4mg /L  
 Percentage change  5.8 /12.6 x100%  46%   
Doubling serum folate (100% rise) halves the risk of NTD (Berry et al., 1999), therefore a 46% 
increase would reduce the total number of UK NTD conceptions by 253/year (from 1100 to 
847). Therefore from the two methods of calculation a mean value of 273 averted NTD 
conceptions is assumed, though this may be an underestimate as improving folate intake 
without reaching the 700 g/day will prevent the NTD malformation in some cases. 
2.4 Estimation of expected cost-benefit balance with folic acid fortification of flour in 
the UK 
Calculations of cost-benefit expected from folic acid fortification will depend on the balance 
between: 
a. The costs of mandatory fortification 
= government reimbursement to millers for adding folic acid 140 g/100mg 
and 
b. government savings from mandatory fortification 
= cost of TOP x drop in number of TOPs done for NTD + average lifetime  
cost of treatment for NTD patients x drop in number of NTDs births 
2.4.1 Cost to the UK government of mandatory folic acid fortification 
The national Association of British and Irish Millers estimated in March 2011 that 5600,000 
tonnes of wheat are milled to make flour/year in the UK. The cost per ton for fortification in 
2011 British Pounds Sterling, estimated from the experience of fortification and monitoring 
expenses in Chile (Llanos et al., 2007) is £0.13/ton. Therefore the expected cost of 
fortification for the UK is £728000/year 
2.4.2 Cost saving benefits from UK mandatory fortification 
Of the 273 averted NTD conceptions averted, 17% (46) will, on past evidence, be NTD births 
which will be associated with a range of lifetime medical costs and 83% (227) of women will 
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opt for selective abortion. Although I could not find a UK estimate for average lifetime costs 
of infants that survive birth with an NTD malformation, there were a range of costs from 
other countries ranging from £15,400 – 326,000. The median figure was £240,000 (Ouyang et 
al., 2007). However, this was an estimation of mean average costs for the USA and USA 
medical expenses are higher than UK prices (even the same drugs cost roughly twice as 
much) and average per capita health expenditure is 2.2 times higher (Kaiser Family 
Foundation 2008). I assume here that the same x2.2 difference will apply to lifetime NTD 
medical costs. Therefore an estimate of mean average lifetime NTD medical costs in the UK 
= £240,0002.2 = £109,091. The UK cost of a therapeutic TOP is £800. Therefore the annual 
saving from fortification in British pounds is: 
109,091x46  800x227  5,018,181  181,600 5,199,781     
2.4.3 Estimated cost benefit of UK mandatory fortification 
Therefore the estimated annual cost saving of fortification in British pounds is: 
4,471,781 –  728,000  5,126,981  
This converts to approximately $7 million. A comparison with the estimated savings for 
Chile in 2001-2001 of only $2.3 million (Llanos et al., 2007) may be largely because their 
health services are less able to cope with complex medical problems that arise in children 
who survive with NTD malformations, early deaths will often occur and this will be 
associated with lower lifetime costs. The Centre for Disease Control and Prevention, USA 
gives a much higher estimate of $453 million/year. Apart from the higher US costs and 
larger population, this estimate includes the loss of earning for parents who stop work to 
care for a spina bifida child which is not included in my estimate for the UK. 
3. Conclusions 
The above figures are only an estimate of the cost-benefit of fortification and there are a 
number of factors that would have to be taken into consideration if fortification was 
implemented in the UK. It will never completely eliminate the need for selective abortion or 
the advisability of women who plan their pregnancies to start taking a FA supplement 
before conception. We estimated (Nichols et al., 2008a) that 45% of women in group B would 
still fail to achieve optimal total folate intake after fortification. When women attend to see a 
primary care doctor or nurse for contraceptive advice or review of ongoing contraception, 
there is an opportunity to raise the importance of pre-conception issues and boost FA 
concordance whenever there is a possibility of a future planned pregnancy. A 
comprehensive package of pre-conception care will be even more effective at reducing the 
risk of NTDs and other congenital malformations as described in section 3.3. The combined 
effect of fortification and adequate preconception advice, linked to contraceptive advice, 
could double the number of NTDs averted. This chapter has concentrated on the benefits of 
FA fortification with respect to averted NTD malformations, but there are other expected 
benefits and several remaining concerns (Table 2). In particular, there is growing evidence 
that other fetal malformations are prevented by fortification and FA supplementation has 
been shown to reduce the risk of intrauterine growth retardation. It is interesting to note 
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that most of these benefits from improving folate status were predicted by Bryan Hibbard 
nearly 50 years ago (Hibbard, 1964) and now we have evidence that improving folate status 
may also prevent childhood cancers (Table 2). Added to this, there is growing evidence that 
FA fortification may deliver more benefits than side effects amongst elders (Table 2). It is too 
soon to claim this as a dependable measure of cost benefit from FA fortification but close 
monitoring of FA intake, blood folate levels and outcomes may help to clarify matters. 
3.1 Remaining concerns 
After fortification a monitoring protocol should include B12 status in view of the 25-43% 
incidence of borderline and moderate vitamin B12 deficiency found in three UK elder 
studies and the suspicion that high folate intake may exacerbate both B12 deficiency and 
associated cognitive decline (Green & Miller, 2005; Table 2) and the evidence for a role for 
borderline vitamin B12 deficiency in NTD (Ray JG et al., 2007; Molloy et al., 2009;), other 
fetal malformations and low birth weight (Table 2). The structure of the UK National Health 
Service (NHS) should make monitoring of B12 status an eminently achievable objective. 
Another concern is that high folate intake may reduce the efficacy of anti-folate drugs used 
in treatment of cancers, rheumatoid arthritis and psoriasis (Smith et al., 2008). This, 
however, is avoidable if these patients are advised to avoid the fortified bread and their 
folate status is monitored by blood tests, when appropriate. The issue of unmetabolised FA 
is unresolved but the North American experience of fortification has been encouraging. The 
predicted problems relating to unmetabolised FA have failed to materialise in the post-
fortification decade. One prediction is that high levels of unmetabolised FA may have an 
adverse effect on immune function in elders by inhibiting the action of NK cells. This has 
only been described in one study (Pfeiffer at al., 2004) and there are no reports to suggest 
that fortification has caused NK cell problems. Lastly, the possibility that high intake of FA 
may influence gene expression by modifying epigenetic imprinting (Smith et al., 2008) and 
this has been demonstrated in animal models but there is, as yet, no evidence that this is 
harmful to humans. Remaining concerns that have to be taken into consideration and 
answered are summarized in table 2. 
 
 Remaining concerns Answers to concerns 
FA 
fortification 
and infant 
health 
15% of group B had predicted TFA 
above 1000 g/day which might 
increase unmetabolised FA in 
circulation and there are purely 
hypothetical suggestions that this 
could have adverse affects on fetal 
development. However, the USA 
have set this safe upper limit due to 
relatively slender evidence that 
masking of vitamin B12 deficiency 
may start at this level (Standing 
Committee on the Scientific 
Evaluation 1998) which is unlikely 
to apply to pregnant women.  
Although the evidence linking TFI 
with NTDs is strongest, there is also 
evidence that FA prevents several 
other major congenital 
malformations, including congenital 
heart defects, limb defects, and 
orofacial clefts (Eichholzer et al., 
2006) and fetal trisomy (Eskes et al., 
2006), and that inadequate maternal 
TFI plays a role in intrauterine 
growth retardation (Relton et al., 
2005a; Relton et al., 2005b) and 
lymphoblastic leukaemia in 
childhood (Thompson et al., 2001). 
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 Remaining concerns Answers to concerns 
FA 
fortification 
and cancers 
Research already mentioned has 
raised the possibility that 
fortification may increase the 
incidence of colorectal and prostate 
cancers. Recent trials failed to 
confirm this risk (Figueiredo et al., 
2011,Gibson et al., 2011). The initial 
increase in these cancers observed 
in USA was either very small or a 
statistical aberration  
FA fortification may have been 
responsible for a drop in the 
incidence of childhood cancers: 
neuroblastomas (French et al., 2003) 
and several other childhood cancers 
(Preston-Martin et al., 1998; Grupp 
SG et al., 2010) and even coloectal 
cancers may be averted in subjects 
with low folate status (Figueiredo et 
al., 2011). 
Affects of 
fortification on 
elders 
Although low folate status is 
known to be a factor in cognitive 
decline, FA intake greater than 
1000 g/day may exacerbate 
borderline vitamin B12 deficiency 
and exacerbate cognitive decline 
(Morris et al., 2004; Clarke et al., 
2004; McCracken et al., 2006; 
Clarke et al., 2007). 
Since fortification was introduced in 
North America a 5% reduction in 
stroke related mortality has been 
observed (Yang et al., 2006; Selhub et 
al., 2000). A well established 
association between folate status and 
cognitive decline was tested in The 
Netherlands using 800 g/day, given 
to subjects with raised serum 
homocysteine. This showed a 
significantl slowing of the rate of 
cognitive decline (Durga et al 2007). 
General inad- 
equacies of FA 
fortification 
FA fortification does nothing for 
borderline deficiencies in the other 
B vitamins that are relevant to fetal 
development and elder health 
issues and the problem of 
unmetabolised FA at the suggested 
level of fortification has not been 
solved. In the Surrey research 
(Nichols et al., 2008a) 45% of 
women still had a sub-optimal FA 
intake and the USA experience 
shows that fortification has failed 
to reduce NTD conceptions in some 
ethnic groups (Yang et al., 2007).  
The established benefits in terms of 
averting NTD malformations may 
outweigh any remaining concerns. 
However, any campaign associated 
with introduction of fortification 
should emphasize the need for 
women to continue to take a pre-
conception B vitamin supplement. 
Public policy on voluntary 
fortification can be used to control 
the excessive levels of FA added to 
some products to minimise the risk 
of pushing FA intake above 1000 
g/day. 
Table 2. Remaining concerns about FA fortification compared with established benefits 
3.2 Opportunistic linkage of advice on pre-conception FA to contraception 
appointments 
First, consider if the patient is likely (or most unlikely) to become pregnant in the future. 
Second, if future pregnancy is a possibility, ask if they expect to “become pregnant” or “start a 
family” at some time in the near or distant future. Lastly, offer them the brochure (outlined 
below) that explains the importance of taking pre-conception FA and, where appropriate, 
advise them to tell their friends (an intelligent young woman will usually want to do this). 
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Before pregnancy 
The government recommends that all women planning to become pregnant should start 
taking folic acid vitamin tablets from at least six weeks before the planned pregnancy and 
up to the twelfth week of pregnancy. 
  
Supplier 
of quality 
 
FOLIC 
ACID 
 
Folic acid plays an important role in the early development of the human embryo. For about 
35 years medical scientists have claimed that lack of folic acid is a cause of miscarriage, 
congenital malformations and handicap but only after particularly convincing research in 
1991, has the government recommended a daily tablet of folic acid for all women.Women 
who have had a previous baby with the rare but serious spinal cord defect "spina bifida" 
should take a relatively high dose of 5 milligrams, but these women are likely to be under 
the care of their doctor or a specialist for this treatment. All other women should ask at their 
chemist for the folic acid 0.4 mg tablet, which should be available at any chemist shop Other 
pre-pregnancy advice which you may or may not be aware of is listed below. 
Non-Smoking 
 
Children of smoking parents are more likely to be born with health problems such as baby 
asthma. Sometimes smoking may cause serious problems for the baby and when babies are 
born very underweight this will usually be partly due to smoking before pregnancy, not just 
during pregnancy. But the effects of smoking are unpredictable and most babies born to 
smoking mothers will appear to be quite normal. Research has shown, however, that these 
babies never do quite so well in later life as the children of non-smokers. 
Alcohol 
Both parents should cut back on alcohol before conception. Views differ as to what is a safe 
limit, but it is probably safest for both of you to cut it out completely 
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Contraception and smear test 
Women should discuss contraception with the family doctor or practice nurse when they start 
to plan for pregnancy. Some delay may be advisable if you have had a pregnancy in the last 
year or two, whatever the outcome. Statistics show that a minimum of 15-month gap between 
children is advisable. This gives the body time to recover fully. Most experts agree that it is 
best to switch from the contraceptive pill to another form of contraception two or three months 
before pregnancy. This allows normal hormone balance to be restored and pregnancy is less 
likely to be troublesome. There is even some evidence that there is an increased risk of 
miscarriage when women become pregnant immediately after stopping the pill. Normally, 
smear tests should be done every three years, but if you are planning to become pregnant, an 
earlier smear test is advisable - i.e. within the year before attempting to conceive. 
Diet 
Although women need extra folic acid as already described, most of the other vitamins, 
micro nutrients and body building nutrients that are needed for fertility and good health 
can be obtained from a really healthy diet with plenty of fresh fruit and vegetables and 
unprocessed whole foods. Recent evidence suggests that eating fish is also beneficial to the 
outcome of pregnancy, especially in prevention of premature birth. How healthy is your 
diet? Everyone thinks his or her diet is "quite good" but most of us are in the "could do 
better" category. Some men and women will benefit from special help with their diet from a 
doctor or dietician. Pre-conception supplements (e.g. Pregnacare) are available which 
contain extra micronutrients, in addition to folic acid. This may be helpful if you feel run 
down and tired or if you have had problems with pregnancy in the past such as a 
miscarriage or postnatal depression. 
Foods which are better avoided before and during pregnancy are: 
- Liver and liver products (contain too much vitamin A) 
- Swordfish and other large fish should not be eaten around the time of conception or 
during pregnancy due to traces of mercury 
- Soft ripe cheese, pate and raw eggs can contain harmful bacteria that infect the placenta 
- Raw meat including cured meat such as parma ham may be a source of toxoplasma 
parasite (see next section). 
- Too much "junk" food such as sweets, biscuits cakes and fizzy drinks 
Lastly, remember that you should build up your strength and bodily resources for pregnancy. 
If you are underweight you may have trouble conceiving and your baby may be underweight 
at birth, which is not a good start for a baby. Now is not the time to lose weight. 
Infection 
Most women will have had a rubella jab at some time, but we now know that it is best to 
have a blood test to check immunity to rubella, even if you did have the jab at school. 
Another infection, which very occasionally causes miscarriage or abnormalities, is 
toxoplasmosis, which is caught mainly from uncooked meat but maybe also from cat faeces. 
You should, perhaps, avoid contact with sick cats or litter trays whilst you are pregnant. 
Chickenpox infection during pregnancy also carries a small but significant risk to both 
mother and baby but if you are sure you have had chickenpox there is nothing to worry 
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about. Women who think they have never had chickenpox should discuss this with their 
doctor. Sexually transmitted diseases are a particular problem when you are planning to 
start a family. Both the man and woman should attend The Genitourinary Clinic if there is 
any suspicion of infection as lingering infection can cause infertility or miscarriage and can 
sometimes have a damaging effect on the baby. 
Medical problems 
If you or your partner has a medical problem such as diabetes or epilepsy you should see 
your doctor for advice before starting a pregnancy. If either of you are on any regular 
medication for any condition (including over the counter medications) you should discuss 
this with a doctor or nurse. If you have a family history of a hereditary disease such as 
Haemophilia or Muscular Dystrophy you should see your doctor about being referred to see 
a genetic counsellor at a hospital clinic. 
3.3 Implications for future research 
Future considerations include the further development of gene testing to determine which 
subjects need a higher dose of FA before a first conception rather than waiting for a NTD 
conception before offering such advice and further consideration of advice on preconception 
supplementation with the other B vitamins and nutrients such as zinc. 
Future research therefore should include: 
 Establishing a way of linking contraceptive advice to pre-conception advice on FA 
supplementation, diet and other aspects of preparation for a healthy pregnancy. 
 Resolving the issue of a safe upper limit for total combined folate and folic acid intake, 
currently set at 1000 g/day. 
 Investigating the biochemistry of unmetabolised FA. 
 Investigating interactions between folate status and B12 status by monitoring reliable 
biomarkers for both after fortification and monitoring outcome (NTDs and cognitive 
decline etc.). 
 Further research into gene-nutrient interactions involving B vitamins and both well 
established genetic variants and candidate genes revealed by genome wide association 
studies. 
A true and accurate cost-benefit analysis for FA fortification can only be completed when 
this research has been done. 
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5. Glossary of acronyms 
DM Mean daily dietary folate for group A women (used for group B calculations) 
FA Folic acid (also has chemical name pteroylmonoglutamate) 
FAD Daily FA intake from supplements 
n Number of participants in a research project 
NTD Neural tube defect (the developmental fault in the early embryo that causes spina 
bifida, hydrocephalus and anencephaly) 
TFI Total folate intake (a combined value for dietary folates and FA) 
TOP Termination of pregnancy 
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